Sattva Sukun Lifecare Intrinsic Value
Sattva Sukun Lifecare (SATTVASUKU) median intrinsic value is ₹1.95 from 2 valuation models (range ₹2–₹2), vs current price ₹0.78 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Analyse Sattva Sukun Lifecare ownership structure to track promoter, FII and institutional holdings.
SATTVASUKU Valuation Methods Summary — DCF, Graham Number & P/E
Sattva Sukun Lifecare intrinsic value across 2 models vs current price ₹0.78 — upside/downside and value range per method. Read Sattva Sukun Lifecare dividend payments for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹1.95 | ₹1.75 - ₹2.15 | +150.0% | Book Value/Share: ₹11.32, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1.56 | ₹1.40 - ₹1.72 | +100.0% | Revenue/Share: ₹14.74, P/S: 0.8x |
SATTVASUKU Intrinsic Value vs Market Price — All Valuation Models
Sattva Sukun Lifecare fair value range ₹2–₹2 vs current market price ₹0.78 across 2 valuation models. For current market price and key ratios, visit Sattva Sukun Lifecare share price today.
SATTVASUKU Intrinsic Value Analysis — Undervalued or Overvalued?
Sattva Sukun Lifecare median intrinsic value ₹1.95, current price ₹0.78 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of SATTVASUKU?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Sattva Sukun Lifecare (SATTVASUKU) is ₹1.95 (median value). With the current market price of ₹0.78, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹1.56 to ₹1.95, indicating ₹1.56 - ₹1.95.
Is SATTVASUKU undervalued or overvalued?
Based on our multi-method analysis, Sattva Sukun Lifecare (SATTVASUKU) appears to be trading below calculated value by approximately 150.0%.
SATTVASUKU Financial Health — Key Ratios vs Industry Benchmarks
Sattva Sukun Lifecare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | -9.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -77.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.50x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SATTVASUKU Cash Flow Quality — Operating & Free Cash Flow
Sattva Sukun Lifecare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-3 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-2 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |